Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Shiraj, Sen"'
Autor:
Bin Zhang, Marsha Crochiere, Anthony W Tolcher, Randy Sweis, Kartik Sehgal, Michael S Gordon, Shui He, Jason Henry, Alexander I Spira, Shiraj Sen, Sandip P Patel, Sondra Smyrnios, Dipali Unadkat
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9890d6d61af94f049829f2a50d034a97
Autor:
Bin Zhang, Gregory Cote, Marsha Crochiere, Anthony W Tolcher, Shui He, Jason Henry, Alexander I Spira, Shiraj Sen, Judy S Wang, Sharon Wilks, Benedito Carneiro, Frank Yung-Chin Tsai, Sondra Smyrnios, Dipali Unadkat
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a464231e8daa460693b1c25a512d31be
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/55b3e7e744454e069ecd0242711f7045
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 83-89 (2020)
Soft tissue sarcomas are a heterogeneous group of rare malignancies with few effective standard therapies. Our understanding of the underlying biology driving tumorigenesis in these mesenchymal tumors have led to a growth in drug development for soft
Externí odkaz:
https://doaj.org/article/fd9a66686bd94bd4870f02b63082a2fb
Autor:
Roberto Carmagnani Pestana, Justin T. Moyers, Jason Roszik, Shiraj Sen, David S. Hong, Aung Naing, Cynthia E. Herzog, Siqing Fu, Sarina A. Piha-Paul, Jordi Rodon, Timothy A. Yap, Daniel D. Karp, Apostolia M. Tsimberidou, Shubham Pant, Maria A. Zarzour, Ravin Ratan, Vinod Ravi, Robert S. Benjamin, Alexander J. Lazar, Wei-Lien Wang, Najat Daw, Jonathan B. Gill, Douglas J. Harrison, Valerae O. Lewis, Christina L. Roland, Shreyaskumar R. Patel, J. Andrew Livingston, Neeta Somaiah, Joseph A. Ludwig, Anthony P. Conley, Nelson Hamerschlak, Richard Gorlick, Funda Meric-Bernstam, Vivek Subbiah
Publikováno v:
Clinical Cancer Research. 29:1708-1718
Purpose: Developing new therapeutics for any of the more than 100 sarcoma subtypes presents a challenge. After progression from standard therapies, patients with sarcoma may be referred for enrollment in early-phase trials. This study aimed to invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78f23ea3e8e64341e0552b9d54de1861
https://doi.org/10.1158/1078-0432.ccr-22-3629
https://doi.org/10.1158/1078-0432.ccr-22-3629
Autor:
Filip Janku, Milind M. Javle, Shiraj Sen, Shubham Pant, Lindsay G. Bramwell, Vivek Subbiah, Tracey Way, David S. Wages, Catherine A. Wheeler, Takeaki Suzuki, Kazunori Saeki, Ruth Ann Subach, Timothy Madden, Gary Maier, Mary J. Johansen, Kin Cheung, Gerald S. Falchook
Publikováno v:
Cancer. 129:1537-1546
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bcfaf443ecb406071cb5888662dc5e3
https://doi.org/10.1002/cncr.34709
https://doi.org/10.1002/cncr.34709
Autor:
Vivek Subbiah, Funda Meric-Bernstam, Richard Gorlick, Nelson Hamerschlak, Anthony P. Conley, Joseph A. Ludwig, Neeta Somaiah, J. Andrew Livingston, Shreyaskumar R. Patel, Christina L. Roland, Valerae O. Lewis, Douglas J. Harrison, Jonathan B. Gill, Najat Daw, Wei-Lien Wang, Alexander J. Lazar, Robert S. Benjamin, Vinod Ravi, Ravin Ratan, Maria A. Zarzour, Shubham Pant, Apostolia M. Tsimberidou, Daniel D. Karp, Timothy A. Yap, Jordi Rodon, Sarina A. Piha-Paul, Siqing Fu, Cynthia E. Herzog, Aung Naing, David S. Hong, Shiraj Sen, Jason Roszik, Justin T. Moyers, Roberto Carmagnani Pestana
Treemap of most common drug mechanisms for patients treated in biomarker-matched studies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff57d97d02e8e004b84f0db0adb9a0a
https://doi.org/10.1158/1078-0432.22634420.v1
https://doi.org/10.1158/1078-0432.22634420.v1
Autor:
Vivek Subbiah, Funda Meric-Bernstam, Richard Gorlick, Nelson Hamerschlak, Anthony P. Conley, Joseph A. Ludwig, Neeta Somaiah, J. Andrew Livingston, Shreyaskumar R. Patel, Christina L. Roland, Valerae O. Lewis, Douglas J. Harrison, Jonathan B. Gill, Najat Daw, Wei-Lien Wang, Alexander J. Lazar, Robert S. Benjamin, Vinod Ravi, Ravin Ratan, Maria A. Zarzour, Shubham Pant, Apostolia M. Tsimberidou, Daniel D. Karp, Timothy A. Yap, Jordi Rodon, Sarina A. Piha-Paul, Siqing Fu, Cynthia E. Herzog, Aung Naing, David S. Hong, Shiraj Sen, Jason Roszik, Justin T. Moyers, Roberto Carmagnani Pestana
Purpose:Developing new therapeutics for any of the more than 100 sarcoma subtypes presents a challenge. After progression from standard therapies, patients with sarcoma may be referred for enrollment in early-phase trials. This study aimed to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b2bbce2946a303e6ad0c658b3cbb82
https://doi.org/10.1158/1078-0432.c.6600059.v1
https://doi.org/10.1158/1078-0432.c.6600059.v1
Autor:
Vivek Subbiah, Funda Meric-Bernstam, Richard Gorlick, Nelson Hamerschlak, Anthony P. Conley, Joseph A. Ludwig, Neeta Somaiah, J. Andrew Livingston, Shreyaskumar R. Patel, Christina L. Roland, Valerae O. Lewis, Douglas J. Harrison, Jonathan B. Gill, Najat Daw, Wei-Lien Wang, Alexander J. Lazar, Robert S. Benjamin, Vinod Ravi, Ravin Ratan, Maria A. Zarzour, Shubham Pant, Apostolia M. Tsimberidou, Daniel D. Karp, Timothy A. Yap, Jordi Rodon, Sarina A. Piha-Paul, Siqing Fu, Cynthia E. Herzog, Aung Naing, David S. Hong, Shiraj Sen, Jason Roszik, Justin T. Moyers, Roberto Carmagnani Pestana
Summary of response outcomes across subgroups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e7f75586d0c115b6f39ae8a9adfd5e4
https://doi.org/10.1158/1078-0432.22634417
https://doi.org/10.1158/1078-0432.22634417
Autor:
Razelle Kurzrock, Sadakatsu Ikeda, Funda Meric-Bernstam, James C. Yao, Robert A. Wolff, Kanwal P.S. Raghav, Abedul Haque, Bhawana George, Kenna R. Mills-Shaw, AmirAli Talasaz, Richard B. Lanman, Kimberly C. Banks, Asif Rashid, Manal M. Hassan, Hesham M. Amin, Jeffrey Morris, Lianchun Xiao, Wei Qiao, Roberto Carmagnani Pestana, Marc Uemura, Reham Abdel-Wahab, Kian H. Lim, Andrea G. Bocobo, Benjamin Tan, Robin K. Kelley, Shiraj Sen, Nora S. Sánchez, Ahmed O. Kaseb
Purpose:Molecular profiling has been used to select patients for targeted therapy and determine prognosis. Noninvasive strategies are critical to hepatocellular carcinoma (HCC) given the challenge of obtaining liver tissue biopsies.Experimental Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc7bcc4a5c85785aef33cebdc420dad
https://doi.org/10.1158/1078-0432.c.6527795.v1
https://doi.org/10.1158/1078-0432.c.6527795.v1